Expression of urinary exosomal miRNA-615-3p and miRNA-3147 in diabetic kidney disease and their association with inflammation and fibrosis

References

• Koye DN, Magliano DJ, Nelson RG, et al. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis. 2018;25(2):121–132.
   PubMed Web of Science ®Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.
   PubMed Web of Science ®Google Scholar
• Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. 2016;316(6):602–610.
   PubMed Web of Science ®Google Scholar
• Matoba K, Takeda Y, Nagai Y, et al. Unraveling the role of inflammation in the pathogenesis of diabetic kidney disease. Int J Mol Sci. 2019;20(14):3393.
   Web of Science ®Google Scholar
• Fan Y, Yi Z, D'Agati VD, et al. Comparison of kidney transcriptomic profiles of early and advanced diabetic nephropathy reveals potential new mechanisms for disease progression. Diabetes. 2019;68(12):2301–2314.
   PubMed Web of Science ®Google Scholar
• Thakur V, Nargis S, Gonzalez M, et al. Role of glycyrrhizin in the reduction of inflammation in diabetic kidney disease. Nephron. 2017;137(2):137–147.
   PubMed Web of Science ®Google Scholar
• Ozbek E. Induction of oxidative stress in kidney. Int J Nephrol. 2012;2012:465897–465897.
   PubMedGoogle Scholar
• Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci. 2013;124(3):139–152.
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang L, Hao J, et al. Up-regulation of microRNA-93 inhibits TGF-beta1-induced EMT and renal fibrogenesis by down-regulation of Orai1. J Pharmacol Sci. 2018;136(4):218–227.
   PubMed Web of Science ®Google Scholar
• Robbins PD, Dorronsoro A, Booker CN. Regulation of chronic inflammatory and immune processes by extracellular vesicles. J Clin Invest. 2016;126(4):1173–1180.
   PubMed Web of Science ®Google Scholar
• Lv LL, Feng Y, Tang TT, et al. New insight into the role of extracellular vesicles in kidney disease. J Cell Mol Med. 2019;23(2):731–739.
   PubMed Web of Science ®Google Scholar
• Matsuyama H, Suzuki HI. Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis. IJMS. 2019;21(1):132.
   Google Scholar
• Wing MR, Ramezani A, Gill HS, et al. Epigenetics of progression of chronic kidney disease: fact or fantasy? Semin Nephrol. 2013;33(4):363–374.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu L, Peng W, et al. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-beta signaling and microRNA-21 expression. J Cell Physiol. 2019;234(10):17925–17936.
   PubMed Web of Science ®Google Scholar
• Ma Z, Li L, Livingston MJ, et al. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease. J Clin Invest. 2020;130(9):5011–5026.
   Google Scholar
• Sheng S, Zou M, Yang Y, et al. miR-23a-3p regulates the inflammatory response and fibrosis in diabetic kidney disease by targeting early growth response 1. In Vitro Cell Dev Biol Anim. 2021;57(8):763–774.
   Google Scholar
• Miranda KC, Bond DT, McKee M, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010;78(2):191–199.
   PubMed Web of Science ®Google Scholar
• Delić D, Eisele C, Schmid R, et al. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients. PLoS One. 2016;11(3):e0150154.
   Google Scholar
• Zhao Y, Shen A, Guo F, et al. Urinary exosomal MiRNA-4534 as a novel diagnostic biomarker for diabetic kidney disease. Front Endocrinol. 2020;11:590–590.
   PubMed Web of Science ®Google Scholar
• Lee W-C, Li L-C, Ng H-Y, et al. Urinary exosomal MicroRNA signatures in nephrotic, biopsy-proven diabetic nephropathy. JCM. 2020;9(4):1220.
   Google Scholar
• Feng Y, Zhong X, Ni HF, et al. Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy. J Transl Med. 2021;19(1):355.
   Google Scholar
• Wang J, Yao Y, Wu J, et al. Identification and analysis of exosomes secreted from macrophages extracted by different methods. Int J Clin Exp Pathol. 2015;8(6):6135–6142.
   Google Scholar
• van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228.
   PubMed Web of Science ®Google Scholar
• Minciacchi VR, Freeman MR, Di Vizio D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol. 2015;40:41–51.
   PubMed Web of Science ®Google Scholar
• Urabe F, Kosaka N, Kimura T, et al. Extracellular vesicles: toward a clinical application in urological cancer treatment. Int J Urol. 2018;25(6):533–543.
   PubMed Web of Science ®Google Scholar
• Mulcahy LA, Pink RC, Carter DRF. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3(1):24641.
   PubMedGoogle Scholar
• Urabe F, Kosaka N, Ito K, et al. Extracellular vesicles as biomarkers and therapeutic targets for cancer. Am J Physiol Cell Physiol. 2020;318(1):C29–C39.
   PubMed Web of Science ®Google Scholar
• Ciardiello C, Leone A, Lanuti P, et al. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation. J Exp Clin Cancer Res. 2019;38(1):317.
   PubMedGoogle Scholar
• Kubo H. Extracellular vesicles in lung disease. Chest. 2018;153(1):210–216.
   PubMed Web of Science ®Google Scholar
• Pamela DT, Paola L, Natalia DP, et al. Liraglutide mitigates TNF-α induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women. Diabetes Metab Res Rev. 2017;33(8).
   Web of Science ®Google Scholar
• Mardpour S, Hamidieh AA, Taleahmad S, et al. Interaction between mesenchymal stromal cell-derived extracellular vesicles and immune cells by distinct protein content. J Cell Physiol. 2019;234(6):8249–8258.
   PubMed Web of Science ®Google Scholar
• Liu H, Li R, Liu T, et al. Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis. Front Immunol. 2020;11:1912.
   PubMed Web of Science ®Google Scholar
• Quaglia M, Dellepiane S, Guglielmetti G, et al. Extracellular vesicles as mediators of cellular crosstalk between immune system and kidney graft. Front Immunol. 2020;11:74.
   PubMed Web of Science ®Google Scholar
• Codagnone M, Recchiuti A, Lanuti P, et al. Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles. Faseb J. 2017;31(5):1856–1866.
   PubMed Web of Science ®Google Scholar
• Wu X, Gao Y, Xu L, et al. Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes. Sci Rep. 2017;7(1):9371.
   PubMedGoogle Scholar
• Munkonda MN, Akbari S, Landry C, et al. Podocyte-derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD36. J Extracell Vesicles. 2018;7(1):1432206.
   PubMed Web of Science ®Google Scholar
• Cricri G, Bellucci L, Montini G, et al. Urinary extracellular vesicles: uncovering the basis of the pathological processes in kidney-related diseases. Int J Mol Sci. 2021;22(12):6507.
   PubMed Web of Science ®Google Scholar
• Erdbrugger U, Le TH. Extracellular vesicles in renal diseases: more than novel biomarkers? J Am Soc Nephrol. 2016;27(1):12–26.
   PubMed Web of Science ®Google Scholar
• Bai Y, Li J, Li J, et al. MiR-615 inhibited cell proliferation and cell cycle of human breast cancer cells by suppressing of AKT2 expression. Int J Clin Exp Med. 2015;8(3):3801–3808.
   PubMed Web of Science ®Google Scholar
• Pu HY, Xu R, Zhang MY, et al. Identification of microRNA-615-3p as a novel tumor suppressor in non-small cell lung cancer. Oncol Lett. 2017;13(4):2403–2410.
   PubMed Web of Science ®Google Scholar
• Laursen EB, Fredsoe J, Schmidt L, et al. Elevated miR-615-3p expression predicts adverse clinical outcome and promotes proliferation and migration of prostate cancer cells. Am J Pathol. 2019;189(12):2377–2388.
   PubMed Web of Science ®Google Scholar
• Liu J, Jia Y, Jia L, et al. MicroRNA 615-3p Inhibits the Tumor Growth and Metastasis of NSCLC via Inhibiting IGF2. Oncol Res. 2019;27(2):269–279.
   Google Scholar
• Zhou JX, Tian Zg Fau - Zhu LF, Zhu Lf Fau - Wu WD, et al. MicroRNA-615-3p promotes the osteoarthritis progression by inhibiting chondrogenic differentiation of bone marrow mesenchymal stem cells. Eur Rev Med Pharmacol Sci. 2018;22(19):6212–6220.
   Google Scholar
• Zhou JX, Tian ZG, Zhu LF, et al. MicroRNA-615-3p promotes the osteoarthritis progression by inhibiting chondrogenic differentiation of bone marrow mesenchymal stem cells. Eur Rev Med Pharmacol Sci. 2018;22(19):6212–6220.
   PubMed Web of Science ®Google Scholar
• Calle P, Hotter G. Macrophage phenotype and fibrosis in diabetic nephropathy. Int J Mol Sci. 2020;21(8):2806.
   Web of Science ®Google Scholar
• Xu LL, Gao W, Chen ZM, et al. Relationships between diabetic nephropathy and insulin resistance, inflammation, Trx, Txnip, CysC and serum complement levels. Eur Rev Med Pharmacol Sci. 2020;24(22):11700–11706.
   PubMed Web of Science ®Google Scholar
• Elsayed MS, El Badawy A, Ahmed A, et al. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus. Diabetes Metab Syndr. 2019;13(1):374–381.
   PubMed Web of Science ®Google Scholar
• Arceo ES, Dizon GA, Tiongco REG. Serum cystatin C as an early marker of nephropathy among type 2 diabetics: a meta-analysis. Diabetes Metab Syndr. 2019;13(6):3093–3097.
   PubMed Web of Science ®Google Scholar
• Higgins SP, Tang Y, Higgins CE, et al. TGF-beta1/p53 signaling in renal fibrogenesis. Cell Signal. 2018;43:1–10.
   PubMed Web of Science ®Google Scholar
• Wilson PG, Thompson JC, Yoder MH, et al. Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-beta inhibition. J Lipid Res. 2017;58(12):2264–2274.
   PubMed Web of Science ®Google Scholar
• Tang PM, Zhang YY, Mak TS, et al. Transforming growth factor-beta signalling in renal fibrosis: from smads to non-coding RNAs. J Physiol. 2018;596(16):3493–3503.
   PubMed Web of Science ®Google Scholar
• Sawires H, Botrous O, Aboulmagd A, et al. Transforming growth factor-beta1 in children with diabetic nephropathy. Pediatr Nephrol. 2019;34(1):81–85.
   PubMed Web of Science ®Google Scholar
• Lei B, Wang D, Zhang M, et al. miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1/TGFBRI axis. J Exp Clin Cancer Res. 2020;39(1):71.
   PubMed Web of Science ®Google Scholar
• Fan G, Gong T, Lin Y, et al. Urine proteomics identifies biomarkers for diabetic kidney disease at different stages. Clin Proteomics. 2021;18(1):32.
   PubMed Web of Science ®Google Scholar
• Jia W, Weng J, Zhu D, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158.
   PubMed Web of Science ®Google Scholar